Tilaknagar Industries Investor Presentation: Key Takeaways
Tilaknagar Industries reported robust Q1 FY27 results with Net Revenue crossing INR 1,000 Cr, driven by the successful integration of Imperial Blue and premiumization strategy.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
53 announcements with these filters
Tilaknagar Industries reported robust Q1 FY27 results with Net Revenue crossing INR 1,000 Cr, driven by the successful integration of Imperial Blue and premiumization strategy.
Tilaknagar Industries announced Q1 FY27 results, reporting a quarterly net revenue of ₹1,046 crore and EBITDA of ₹169 crore, driven by strong volume growth across its brands.
Tilaknagar Industries Ltd reported revenue from operations of ₹2,252 Cr (+165.4% YoY) and net profit of ₹31.6 Cr (-64.3% YoY) for Q1 FY27.
Tilaknagar Industries has issued a postal ballot notice seeking shareholder approval for the re-appointment of Ms. Swapna Shah as a Non-Executive Non-Independent Director.
Tilaknagar Industries Ltd has filed its shareholding pattern for the quarter ending June 30, 2026. This disclosure provides details on the company's current ownership structure.
Tilaknagar Industries will hold a Board Meeting on July 27, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Tilaknagar Industries reported a record 3.4 million cases sold in June 2026, its highest monthly volume ever. It also launched four new premium spirits in West Bengal.
Tilaknagar Industries invested Rs. 2 Crore in Bartisans via CCPS. This capital infusion strengthens its stake in the subsidiary.
Tilaknagar Industries invested Rs.2 Crore in Round the Cocktails Private Limited. This increases its shareholding in the entity to 41.45%.
Tilaknagar Industries' brands rank among the top global spirits in Drinks International's Millionaires' Club 2026. The award highlights the firm’s strong portfolio and growth momentum.
Mr. Kishorekumar Ganpatrao Mhatre ceased to be an Independent Director at Tilaknagar Industries following the completion of his tenure. This planned departure reflects routine board rotation.
TILAKNAGAR Q4 FY26 results show landmark growth following the Imperial Blue acquisition integration. Revenue reached ₹949cr with consolidated EBITDA margins at 15.5%. Strategy focuses on premiumization, debt reduction, and pan-India distribution expansion.
Tilaknagar Industries filed its Annual Secretarial Compliance Report for FY2026. The report by Parikh & Associates confirms overall regulatory compliance with a minor past administrative fine.
Tilaknagar Industries approved the re-appointment of MD Amit Dahanukar and Executive Director C.R. Ramesh for three-year terms. These leadership renewals ensure management continuity for the company.
Tilaknagar Industries Limited allotted 3,03,050 equity shares following the exercise of employee stock options. This increases the company's paid-up share capital to 247,473,875 shares.
Tilaknagar Industries recommended a final dividend of ₹1 per equity share for FY 2025-2026. This distribution rewards shareholders following the board's approval on May 29.
Tilaknagar Industries reported record FY26 revenue of ₹2,346 Crore, achieving 20 million cases in volume. The board recommended a dividend of Re. 1 per share.
Tilaknagar Industries reported record FY26 sales of ~20mn cases, driven by the acquisition of Imperial Blue and Mansion House Brandy reaching 10mn cases. Strategy focuses on premiumization and pan-India distribution.
Tilaknagar Industries approved the amalgamation of wholly owned subsidiaries Punjabexpo Breweries and Vahni Distilleries. The merger aims to consolidate operations, reduce overheads, and improve organizational efficiency.
Tilaknagar Industries Ltd reported revenue from operations of ₹2,090 Cr (+143.3% YoY) and a net loss of ₹14.9 Cr for Q4 FY26.
Tilaknagar Industries reported audited FY26 results and recommended a Rs. 1 per share dividend. It also approved a ₹30 Crore investment in a new Nigerian subsidiary.
Tilaknagar Industries scheduled a board meeting on May 29, 2026, to approve annual audited financial results. Directors will also consider a potential dividend recommendation.
Tilaknagar Industries commenced production at its expanded Andhra Pradesh facility following government approval. The ₹59 Crore investment increases bottling capacity six-fold to 36 lakh cases annually.